Clinical Trial Update: Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

View source ↗

Summary

Clinical trial update on the delivery and toxicity of adjuvant chemotherapy in patients with resected non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Adjuvant, Chemotherapy | Status: COMPLETED